Approval · Notice of Compliance 32338 · 2023
LEVODEXA: Notice of Compliance 32338
Issued December 12, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32338
- Date
- December 12, 2023
- Company
- Xediton Pharmaceuticals Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEVODEXA | 02543745 | Marketed |
Medicinal ingredients
- DEXAMETHASONE 0.1 PER
- LEVOFLOXACIN 0.5 PER